Logo of brmedjLink to Publisher's site
Br Med J. 1959 Mar 14; 1(5123): 663–680.
PMCID: PMC1993129
PMID: 13629086

Present Position of Immunization Against Poliomyelitis with Live Virus Vaccines*

Albert B. Sabin
Author information ► Copyright and License information ► Disclaimer

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (4.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 663
663
icon of scanned page 664
664
icon of scanned page 665
665
icon of scanned page 666
666
icon of scanned page 667
667
icon of scanned page 668
668
icon of scanned page 669
669
icon of scanned page 670
670
icon of scanned page 671
671
icon of scanned page 672
672
icon of scanned page 673
673
icon of scanned page 674
674
icon of scanned page 675
675
icon of scanned page 676
676
icon of scanned page 677
677
icon of scanned page 678
678
icon of scanned page 679
679
icon of scanned page 680
680
 

Images in this article

Fig. 2
Fig. 2
on p.665
Fig. 3
Fig. 3
on p.665
Fig. 4
Fig. 4
on p.666
Fig. 5
Fig. 5
on p.666
Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BODIAN D, MORGAN IM, SCHWERDT CE. Virus and host factors influencing the titer of Lansing poliomyelitis virus in monkeys, cotton rats and mice. Am J Hyg. 1950 Jan;51(1):126–illust. [PubMed]
  • CLARKE SK, GOFFE AP, STUART-HARRIS CH, HERZOG EG. A small-scale trial of type III attenuated living poliovirus vaccine. Br Med J. 1958 Nov 15;2(5106):1188–1193. [PMC free article] [PubMed]
  • COURTOIS G, FLACK A, JERVIS GA, KOPROWSKI H, NINANE G. Preliminary report on mass vaccination of man with live attenuated poliomyelitis virus in the Belgian Congo and Ruanda-Urundi. Br Med J. 1958 Jul 26;2(5090):187–190. [PMC free article] [PubMed]
  • DANE DS, DICK GW, BRIGGS M, NELSON R. Vaccination against poliomyelitis with live virus vaccines. 5. Neutralizing antibody levels one year after vaccination. Br Med J. 1958 Nov 15;2(5106):1187–1188. [PMC free article] [PubMed]
  • DAVIS DC, LIPSON MJ, CARVER DH, MELNICK JL, ROBBINS FC. The degree and duration of poliomyelitis virus excretion among vaccinated household contacts of clinical cases of poliomyelitis. Pediatrics. 1958 Jul;22(1 Pt 1):33–40. [PubMed]
  • DANE DS, DICK GW. Vaccination against poliomyelitis with live virus vaccines. III. The evaluation to TN and SM virus vaccines. Br Med J. 1957 Jan 12;1(5010):70–74. [PubMed]
  • FOX JP, GELFAND HM, LEBLANC DR, CONWELL DP. Studies on the development of natural immunity to poliomyelitis in Louisiana. I. Over-all plan, methods and observations as to patterns of seroimmunity in the study group. Am J Hyg. 1957 May;65(3):344–366. [PubMed]
  • HORSTMANN DM, NIEDERMAN JC, MELNICK JL, PAUL JR. Poliomyelitis: comparison of responses of vaccinated and naturally immune humans to ingestion of attenuated poliovirus. Trans Assoc Am Physicians. 1957;70:91–101. [PubMed]
  • HSIUNG GD, MELNICK JL. Effect of sodium bicarbonate concentration on plaque formation of virulent and attenuated polioviruses. J Immunol. 1958 Apr;80(4):282–293. [PubMed]
  • KANDA Y, MELNICK JL. In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells. J Exp Med. 1959 Jan 1;109(1):9–24. [PMC free article] [PubMed]
  • LE BOUVIER GL. On the rise and decline of poliovirus antibodies in different human populations. Am J Hyg. 1957 Nov;66(3):342–362. [PubMed]
  • LENNETTE EH, SCHMIDT NJ. Studies on the development and persistence of complement-fixing and neutralizing antibodies in human poliomyelitis. Am J Hyg. 1957 Mar;65(2):210–238. [PubMed]
  • SABIN AB. Characteristics and genetic potentialities of experimentally produced and naturally occurring variants of poliomyelitis virus. Ann N Y Acad Sci. 1955 Sep 27;61(4):924–939. [PubMed]
  • VERLINDE JD, WILTERDINK JB, HOFMAN B, KRET A. Actieve immunisatie tegen poliomyelitis met een vaccin van verzwakt virus. II. Eerste mededeling over de toepassing van bet Sabin-vaccin in Nederland. Ned Tijdschr Geneeskd. 1958 Jun 14;102(24):1144–1149. [PubMed]
  • VOGT M, DULBECCO R, WENNER HA. Mutants of poliomyelitis viruses with reduced efficiency of plating in acid medium and reduced neuropathogenicity. Virology. 1957 Aug;4(1):141–155. [PubMed]
Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group